CVS Health Co. (NYSE:CVS) Shares Acquired by Swedbank AB

Swedbank AB increased its stake in CVS Health Co. (NYSE:CVS) by 1.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,405,812 shares of the pharmacy operator’s stock after purchasing an additional 16,923 shares during the quarter. Swedbank AB’s holdings in CVS Health were worth $63,107,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of CVS. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health in the third quarter valued at about $25,000. Ridgewood Investments LLC grew its stake in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares in the last quarter. Livelsberger Financial Advisory acquired a new stake in CVS Health during the 3rd quarter valued at approximately $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health during the 3rd quarter valued at approximately $31,000. Finally, Reston Wealth Management LLC acquired a new stake in CVS Health during the 3rd quarter valued at approximately $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 0.6 %

Shares of CVS Health stock opened at $57.00 on Thursday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The business’s fifty day moving average price is $51.27 and its two-hundred day moving average price is $56.18. The company has a market capitalization of $71.73 billion, a P/E ratio of 14.47, a PEG ratio of 0.80 and a beta of 0.59.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the previous year, the firm posted $2.21 EPS. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, research analysts forecast that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.67%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on CVS shares. Barclays lowered their price objective on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Piper Sandler lowered their price objective on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Royal Bank of Canada decreased their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Finally, Evercore ISI lifted their target price on CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Monday. One research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.